Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Extracellular vesicles and ctDNA in lung cancer: biomarker sources and therapeutic applications
Cheng-Liang Huang, Sitong Liu, Tong Xiang, et al.
Cancer Chemotherapy and Pharmacology (2018) Vol. 82, Iss. 2, pp. 171-183
Closed Access | Times Cited: 20

Showing 20 citing articles:

Predictive biomarkers of response for immune checkpoint inhibitors in non–small-cell lung cancer
Arsela Prelaj, Rebecca Tay, Roberto Ferrara, et al.
European Journal of Cancer (2018) Vol. 106, pp. 144-159
Closed Access | Times Cited: 188
Extracellular vesicles: novel communicators in lung diseases
Aradhana Mohan, Stuti Agarwal, Matthias Clauss, et al.
Respiratory Research (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 108
Recent Advances in Microfluidic Platforms Applied in Cancer Metastasis: Circulating Tumor Cells' (CTCs) Isolation and Tumor‐On‐A‐Chip
Zhengjie Lin, Guanyi Luo, Weixiang Du, et al.
Small (2019) Vol. 16, Iss. 9
Closed Access | Times Cited: 105
Extracellular vesicles as cancer liquid biopsies: from discovery, validation, to clinical application
Zhen Zhao, Jia Fan, Yen‐Michael S. Hsu, et al.
Lab on a Chip (2019) Vol. 19, Iss. 7, pp. 1114-1140
Open Access | Times Cited: 84
Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer
Wenhua Liang, Kaican Cai, Chun Chen, et al.
Translational Lung Cancer Research (2020) Vol. 9, Iss. 6, pp. 2696-2715
Open Access | Times Cited: 73
Recent progress of biosensors for the detection of lung cancer markers
Shanchuan Chen, Minghan Li, Ting Weng, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 25, pp. 5715-5747
Closed Access | Times Cited: 22
Interrelation between extracellular vesicles miRNAs with chronic lung diseases
Rajib Dhar, Sayantanee Mukherjee, Nobendu Mukerjee, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 11, pp. 4021-4036
Closed Access | Times Cited: 23
Liquid biopsies using pleural effusion-derived exosomal DNA in advanced lung adenocarcinoma
Zhengbo Song, Zhijian Cai, Junrong Yan, et al.
Translational Lung Cancer Research (2019) Vol. 8, Iss. 4, pp. 392-400
Open Access | Times Cited: 30
Longitudinal nonlinear mixed effects modeling of EGFR mutations in ctDNA as predictor of disease progression in treatment of EGFR‐mutant non‐small cell lung cancer
Julie M. Janssen, Remy B. Verheijen, Tirsa T van Duijl, et al.
Clinical and Translational Science (2022) Vol. 15, Iss. 8, pp. 1916-1925
Open Access | Times Cited: 17
Salivary Extracellular Vesicles in Detection of Cancers Other than Head and Neck: A Systematic Review
Wojciech Owecki, Karolina Wojtowicz, Kacper Nijakowski
Cells (2025) Vol. 14, Iss. 6, pp. 411-411
Open Access
Landscape of tumor and immune system cells-derived exosomes in lung cancer: mediators of antitumor immunity regulation
Alejandro Castillo-Peña, Sonia Molina‐Pinelo
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
The Labyrinth of Product Development and Regulatory Approvals in Liquid Biopsy Diagnostics
Federico Goodsaid
Clinical and Translational Science (2019) Vol. 12, Iss. 5, pp. 431-439
Open Access | Times Cited: 24
Extracellular Vesicles in Smoking-Mediated HIV Pathogenesis and their Potential Role in Biomarker Discovery and Therapeutic Interventions
Sanjana Haque, Sunitha Kodidela, Kelli Gerth, et al.
Cells (2020) Vol. 9, Iss. 4, pp. 864-864
Open Access | Times Cited: 17
Exosomes in the lung cancer microenvironment: biological functions and potential use as clinical biomarkers
Runzhi Qi, Yuwei Zhao, Qiujun Guo, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Molecular markers related to immunosurveillance as predictive and monitoring tools in non-small cell lung cancer: recent accomplishments and future promises
Kleita Michaelidou, Sofia Agelaki, Konstantinos Mavridis
Expert Review of Molecular Diagnostics (2020) Vol. 20, Iss. 3, pp. 335-344
Closed Access | Times Cited: 15
Molecular Profiling of Liquid Biopsies for Precision Oncology
Edgar Gonzalez‐Kozlova
Advances in experimental medicine and biology (2022), pp. 235-247
Closed Access | Times Cited: 7
Liquid Biopsy Biomarkers for Immunotherapy in Non-Small Cell Lung Carcinoma: Lessons Learned and the Road Ahead
Jesus Hita-Millan, Ángel Carracedo, Ceres Fernández‐Rozadilla
Journal of Personalized Medicine (2021) Vol. 11, Iss. 10, pp. 971-971
Open Access | Times Cited: 5
Liquid Biopsies: As an Emerging Tool in Cancer Diagnosis and Monitoring Therapies in Metastasis
Omkar Khade, Sagar Nagrekar, Vivek Parab, et al.
Diseases & Research (2023) Vol. 3, Iss. 1, pp. 41-54
Open Access
Tobacco/HIV-1-Induced Myeloid Cell-Derived Extracellular Vesicles in HIV-1 Pathogenesis
Sanjana Haque
(2020)
Open Access
Nano-Biomaterials for Immunotherapy Applications
Pooja Saxena
BENTHAM SCIENCE PUBLISHERS eBooks (2022), pp. 30-48
Closed Access
Page 1

Scroll to top